180 related articles for article (PubMed ID: 22664499)
21. Relationships between increased circulating YKL-40, IL-6 and TNF-α levels and phenotypes and disease activity of primary Sjögren's syndrome.
Chen C; Liang Y; Zhang Z; Zhang Z; Yang Z
Int Immunopharmacol; 2020 Nov; 88():106878. PubMed ID: 32791244
[TBL] [Abstract][Full Text] [Related]
22. Elevation of Serum IL-35 in Patients with Primary Sjögren's Syndrome.
Han M; Li Y; Liu S; Jiang S; Yuan L; Xia L; Shen H; Lu J
J Interferon Cytokine Res; 2018 Oct; 38(10):452-456. PubMed ID: 30256702
[TBL] [Abstract][Full Text] [Related]
23. Interleukin 17E associates with haematologic involvement and autoantibody production in primary Sjögren's syndrome.
Zhao X; Gan Y; Jin Y; He J; Jia R; Li Y; Luan H; Ye H; Wang Q; Liu Y; Shen D; Sun X; Li Z
Clin Exp Rheumatol; 2021; 39(2):378-384. PubMed ID: 32573420
[TBL] [Abstract][Full Text] [Related]
24. Serum concentrations of cardiac troponin-I in patients with rheumatoid arthritis, systemic lupus erythematosus, primary Sjogren's syndrome and Graves' disease.
Al-Awadhi AM; Olusi S; Hasan EA; Abdullah A
Singapore Med J; 2007 Sep; 48(9):847-9. PubMed ID: 17728967
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of rheumatoid factor as an immunological and prognostic marker in PSS patients.
Maślińska M; Mańczak M; Kwiatkowska B
Clin Rheumatol; 2019 May; 38(5):1301-1307. PubMed ID: 30810912
[TBL] [Abstract][Full Text] [Related]
26. Serologic profile and clinical markers of Sjögren syndrome in patients with rheumatoid arthritis.
Oliveira HF; de Souza TR; Carvalho CN; Duarte A; Carvalho AT; Leão JC; Gueiros LA
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jun; 119(6):628-35. PubMed ID: 25956216
[TBL] [Abstract][Full Text] [Related]
27. Anti-CCP and antikeratin antibodies in rheumatoid arthritis, primary Sjögren's syndrome, and Wegener's granulomatosis.
Kamali S; Polat NG; Kasapoglu E; Gul A; Ocal L; Aral O; Konice M; Badur S; Inanc M
Clin Rheumatol; 2005 Nov; 24(6):673-6. PubMed ID: 15926038
[TBL] [Abstract][Full Text] [Related]
28. Elevated nitric oxide production in patients with primary Sjögren's syndrome.
Wanchu A; Khullar M; Sud A; Bambery P
Clin Rheumatol; 2000; 19(5):360-4. PubMed ID: 11055824
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of IgA Anti-α-fodrin Antibodies in Combination with Rheumatoid Factor and/or Antinuclear Antibodies as Substitute Immunological Criterion in Sjögren Syndrome with Negative Anti-SSA/SSB Antibodies.
Hernández-Molina G; Nuñez-Alvarez C; Avila-Casado C; Llorente L; Hernández-Hernández C; Calderillo ML; Marroquín V; Recillas-Gispert C; Romero-Díaz J; Sánchez-Guerrero J
J Rheumatol; 2016 Oct; 43(10):1852-1857. PubMed ID: 27481899
[TBL] [Abstract][Full Text] [Related]
30. Male patients with primary Sjögren's syndrome: A distinct clinical subgroup?
Park Y; Lee J; Park SH; Kwok SK
Int J Rheum Dis; 2020 Oct; 23(10):1388-1395. PubMed ID: 32918388
[TBL] [Abstract][Full Text] [Related]
31. Previous diagnosis of Sjögren's Syndrome as rheumatoid arthritis or systemic lupus erythematosus.
Rasmussen A; Radfar L; Lewis D; Grundahl K; Stone DU; Kaufman CE; Rhodus NL; Segal B; Wallace DJ; Weisman MH; Venuturupalli S; Kurien BT; Lessard CJ; Sivils KL; Scofield RH
Rheumatology (Oxford); 2016 Jul; 55(7):1195-201. PubMed ID: 26998859
[TBL] [Abstract][Full Text] [Related]
32. Increased CD200 levels in peripheral blood mononuclear cells of patients with primary Sjögren's syndrome.
Liu TT; Zeng XP; Gu ML; Deng AM
Int J Rheum Dis; 2020 May; 23(5):654-660. PubMed ID: 32180363
[TBL] [Abstract][Full Text] [Related]
33. Matrix metalloproteinase 9 (MMP-9) gene polymorphism and MMP-9 plasma levels in primary Sjogren's syndrome.
Hulkkonen J; Pertovaara M; Antonen J; Pasternack A; Hurme M; Pöllänen P; Lehtimäki T
Rheumatology (Oxford); 2004 Dec; 43(12):1476-9. PubMed ID: 15316122
[TBL] [Abstract][Full Text] [Related]
34. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.
Retamozo S; Akasbi M; Brito-Zerón P; Bosch X; Bove A; Perez-de-Lis M; Jimenez I; Soto-Cardenas MJ; Gandia M; Diaz-Lagares C; Viñas O; Siso A; Perez-Alvarez R; Yague J; Ramos-Casals M
Clin Exp Rheumatol; 2012; 30(5):686-92. PubMed ID: 22704838
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of antibodies and minor salivary gland biopsy in the study of sicca syndrome in daily clinical practice.
Santiago ML; Seisdedos MR; Garcia Salinas RN; Catalán Pellet A; Villalón L; Secco A
Reumatol Clin; 2015; 11(3):156-60. PubMed ID: 25579246
[TBL] [Abstract][Full Text] [Related]
36. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis.
Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J
Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764
[TBL] [Abstract][Full Text] [Related]
37. Salivary and serum interleukin 6 in primary Sjögren's syndrome.
Grisius MM; Bermudez DK; Fox PC
J Rheumatol; 1997 Jun; 24(6):1089-91. PubMed ID: 9195514
[TBL] [Abstract][Full Text] [Related]
38. Elevated plasma midkine and pleiotrophin levels in patients with systemic lupus erythematosus.
Wu GC; Yuan H; Pan HF; Ye DQ
Oncotarget; 2017 Jun; 8(25):40181-40189. PubMed ID: 27903979
[TBL] [Abstract][Full Text] [Related]
39. Exploring the relationship between oxidative stress status and inflammatory markers during primary Sjögren's syndrome: A new approach for patient monitoring.
Benchabane S; Sour S; Zidi S; Hadjimi Z; Nabila L; Acheli D; Bouzenad A; Belguendouz H; Touil-Boukoffa C
Int J Immunopathol Pharmacol; 2024; 38():3946320241263034. PubMed ID: 38901876
[TBL] [Abstract][Full Text] [Related]
40. Identification of a Novel Serum Proteomic Signature for Primary Sjögren's Syndrome.
Padern G; Duflos C; Ferreira R; Assou S; Guilpain P; Maria ATJ; Goulabchand R; Galea P; Jurtela M; Jorgensen C; Pers YM
Front Immunol; 2021; 12():631539. PubMed ID: 33708222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
